| scholarly article | Q13442814 |
| P2093 | author name string | Roberto Stasi | |
| Sergio Amadori | |||
| P2860 | cites work | Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes | Q33966333 |
| Anti-tumor necrosis factor therapies | Q34239036 | ||
| Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; Malignancy | Q40702666 | ||
| Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. | Q40921115 | ||
| Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group | Q29616063 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 334-337 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes | |
| P478 | volume | 116 |
| Q35596219 | Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease |
| Q42527369 | Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies |
| Q36219655 | Emerging drugs for the treatment of myelodysplastic syndrome |
| Q33224648 | Immune pathophysiology of aplastic anemia |
| Q37222206 | Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success |
| Q53632729 | Myelodysplastic syndrome. |
| Q84122086 | New agents in myelodysplastic syndromes |
| Q35829958 | Novel therapies for myelodysplastic syndromes |
| Q40482604 | Remicade as TNF suppressor in patients with myelodysplastic syndromes. |
| Q50114615 | The bone-marrow niche in MDS and MGUS: implications for AML and MM. |
| Q34996351 | The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002). |
| Q36348615 | Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood. |
| Q83995841 | Treatment of myelodysplastic syndromes with exogenous erythropoietin: a new therapeutic paradigm |
| Q35944694 | Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group |
Search more.